February 2016 Life Science Industry Research Reports

Diabetic Nephropathy – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Diabetic Nephropathy – Pipeline Review, H1 2016′, provides an overview of the Diabetic Nephropathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Diabetic Nephropathy, […]

Acute Pain – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Acute Pain – Pipeline Review, H1 2016′, provides an overview of the Acute Pain pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Pain, […]

Dementia – Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Dementia – Pipeline Review, H1 2016′, provides an overview of the Dementia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Dementia, complete with analysis by […]

Global Markets Direct’s, ‘Chemotherapy Induced Neutropenia – Pipeline Review, H1 2016′, provides an overview of the Chemotherapy Induced Neutropenia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chemotherapy Induced Neutropenia, complete with analysis by stage […]

Global Markets Direct’s, ‘Indolent Lymphoma – Pipeline Review, H1 2016′, provides an overview of the Indolent Lymphoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Indolent Lymphoma, complete with analysis by stage of development, drug […]

Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia – Pipeline Review, H1 2016′, provides an overview of the B-Cell Chronic Lymphocytic Leukemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for B-Cell Chronic Lymphocytic Leukemia, complete with […]

Global Markets Direct’s, ‘Cancer Cachexia – Pipeline Review, H1 2016′, provides an overview of the Cancer Cachexia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cancer Cachexia, complete with analysis by stage of development, drug […]

Global Markets Direct’s, ‘Hyperlipidemia – Pipeline Review, H1 2016′, provides an overview of the Hyperlipidemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hyperlipidemia, complete with analysis by stage of development, drug target, mechanism of […]

Global Markets Direct’s, ‘Amyloidosis – Pipeline Review, H1 2016′, provides an overview of the Amyloidosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Amyloidosis, complete with analysis by stage of development, drug target, mechanism of […]

Global Markets Direct’s, ‘Erectile Dysfunction – Pipeline Review, H1 2016′, provides an overview of the Erectile Dysfunction pipeline landscape. The report provides comprehensive information on the therapeutics under development for Erectile Dysfunction, complete with analysis by stage of development, drug […]